FindTrial
Sign In

Femoral head autografting to augment acetabular deficiency in total hip replacement of patients with osteoarthritis of the hip secondary to Crowe type III developmental dysplasia

Femoral head autografting to augment acetabular deficiency in total hip replacement of patients with osteoarthritis of the hip secondary to Crowe type III developmental dysplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014563
Enrollment
Unknown
Registered
2018-01-21
Start date
2018-01-22
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with osteoarthritis of the hip secondary to Crowe type III developmental dysplasia

Interventions

Case series:femoral head autografting to augment acetabular deficiency

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. patients with osteoarthritis of the hip secondary to Crowe type III developmental dysplasia from 2011 to 2015; 2. patients undergone primary total replacement; 3. using femoral head autografting to augment acetabular deficiency in total hip replacement.

Exclusion criteria

Exclusion criteria: 1. patients with revision replacement; 2. using tantalum metal block for bone defect; 3. acetabular reconstruction with high hip center.

Design outcomes

Primary

MeasureTime frame
revision rate;joint function score;—

Secondary

MeasureTime frame
complications;Radiographic assessment;—

Countries

China

Contacts

Public ContactPengde Kang

West China Hospital, Sichuan University

kangpd@163.com+86 028 85422426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026